Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ed Schuuring

Showing results (141-150 of 210) with videos related to

Pageof 21
Sort By:
Molecular Oncology|May 25, 2024
Levels of circulating tumor DNA correlate with tumor volume in gastro-intestinal stromal tumors: an exploratory long-term follow-up studyRoos F Bleckman, Charlotte M S C Haag, Naomi Rifaela, et al.
Epigenetics|September 29, 2012
Genome-wide methylation profiling identifies hypermethylated biomarkers in high-grade cervical intraepithelial neoplasiaÁgnes Lendvai, Frank Johannes, Christina Grimm, et al.
Journal of Clinical Pathology|July 12, 2014
Guidance for laboratories performing molecular pathology for cancer patientsIan A Cree, Zandra Deans, Marjolijn J L Ligtenberg, et al.
Plos One|March 24, 2016
Chronic Obstructive Pulmonary Disease Is Not Associated with KRAS Mutations in Non-Small Cell Lung CancerAli Saber, Anthonie J van der Wekken, Gerald S M A Kerner, et al.
Cancer Metastasis Reviews|May 6, 2020
Clinical utility of circulating tumor DNA as a response and follow-up marker in cancer therapyPieter A Boonstra, Thijs T Wind, Michel van Kruchten, et al.
Molecular Oncology|December 7, 2023
A scenario-drafting study to explore potential future implementation pathways of circulating tumor DNA testing in oncologyAstrid Kramer, Carmen Rubio-Alarcón, Daan van den Broek, et al.
Cancers|October 6, 2020
An All-In-One Transcriptome-Based Assay to Identify Therapy-Guiding Genomic Aberrations in Nonsmall Cell Lung Cancer PatientsJiacong Wei, Anna A Rybczynska, Pei Meng, et al.
JCO Precision Oncology|July 14, 2022
Cost-Effectiveness of Parallel Versus Sequential Testing of Genetic Aberrations for Stage IV Non-Small-Cell Lung Cancer in the NetherlandsHenri B Wolff, Elisabeth M P Steeghs, Zakile A Mfumbilwa, et al.
The Journal of Molecular Diagnostics : JMD|September 13, 2024
Comparison of Results from Two Commercially Available In-House Tissue-Based Comprehensive Genomic Profiling Solutions: Research Use Only AVENIO Tumor Tissue Comprehensive Genomic Profiling Kit and TruSight Oncology 500 AssayHans-Peter Adams, Matthew C Hiemenz, Kay Hertel, et al.
The Laryngoscope|January 23, 2009
Radiotherapy in laryngeal carcinoma: can a panel of 13 markers predict response?Maarten A M Wildeman, Johan H Gibcus, Michael Hauptmann, et al.
Pageof 21

Showing results (141-150 of 210) with videos related to

Sort By:
Pageof 21
Molecular Oncology|May 25, 2024
Levels of circulating tumor DNA correlate with tumor volume in gastro-intestinal stromal tumors: an exploratory long-term follow-up studyRoos F Bleckman, Charlotte M S C Haag, Naomi Rifaela, et al.
Epigenetics|September 29, 2012
Genome-wide methylation profiling identifies hypermethylated biomarkers in high-grade cervical intraepithelial neoplasiaÁgnes Lendvai, Frank Johannes, Christina Grimm, et al.
Journal of Clinical Pathology|July 12, 2014
Guidance for laboratories performing molecular pathology for cancer patientsIan A Cree, Zandra Deans, Marjolijn J L Ligtenberg, et al.
Plos One|March 24, 2016
Chronic Obstructive Pulmonary Disease Is Not Associated with KRAS Mutations in Non-Small Cell Lung CancerAli Saber, Anthonie J van der Wekken, Gerald S M A Kerner, et al.
Cancer Metastasis Reviews|May 6, 2020
Clinical utility of circulating tumor DNA as a response and follow-up marker in cancer therapyPieter A Boonstra, Thijs T Wind, Michel van Kruchten, et al.
Molecular Oncology|December 7, 2023
A scenario-drafting study to explore potential future implementation pathways of circulating tumor DNA testing in oncologyAstrid Kramer, Carmen Rubio-Alarcón, Daan van den Broek, et al.
Cancers|October 6, 2020
An All-In-One Transcriptome-Based Assay to Identify Therapy-Guiding Genomic Aberrations in Nonsmall Cell Lung Cancer PatientsJiacong Wei, Anna A Rybczynska, Pei Meng, et al.
JCO Precision Oncology|July 14, 2022
Cost-Effectiveness of Parallel Versus Sequential Testing of Genetic Aberrations for Stage IV Non-Small-Cell Lung Cancer in the NetherlandsHenri B Wolff, Elisabeth M P Steeghs, Zakile A Mfumbilwa, et al.
The Journal of Molecular Diagnostics : JMD|September 13, 2024
Comparison of Results from Two Commercially Available In-House Tissue-Based Comprehensive Genomic Profiling Solutions: Research Use Only AVENIO Tumor Tissue Comprehensive Genomic Profiling Kit and TruSight Oncology 500 AssayHans-Peter Adams, Matthew C Hiemenz, Kay Hertel, et al.
The Laryngoscope|January 23, 2009
Radiotherapy in laryngeal carcinoma: can a panel of 13 markers predict response?Maarten A M Wildeman, Johan H Gibcus, Michael Hauptmann, et al.
Pageof 21